IBIO vs INO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

IBIO

53.3
AI Score
VS
IBIO Wins

INO

30.4
AI Score

Investment Advisor Scores

IBIO

53score
Recommendation
HOLD

INO

30score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IBIO INO Winner
Revenue 1.07M 298,901 IBIO
Net Income -7.55M -74.90M IBIO
Net Margin -702.4% -25058.5% IBIO
Operating Income -8.34M -60.10M IBIO
ROE -9.6% 220.8% INO
ROA -8.5% -124.6% IBIO
Total Assets 88.65M 60.14M IBIO
Cash 45.44M 46.96M INO
Current Ratio 9.48 0.57 IBIO

Relative Price Performance (Last 90 Days)

IBIO 1M: -2.4% · 3M: -46.7% INO 1M: +48.1% · 3M: +33.9%

Current Technical Phase

IBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.3%), weak momentum, RSI 41

RSI (14): 41.3 · Price: $0.76

INO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.3% over 20 days), RSI 56

RSI (14): 56.3 · Price: $1.46

Fundamentals Snapshot

Metric IBIO INO
Market Cap — —
Forward P/E -2.5 -3.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% -1.0%
Gross Margin 1.0% —
Operating Margin -301.4% 0.0%
EPS -0.27 -0.90
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IBIO is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.